• logo
  • UKUK
  • Products
    • Search for Product
      • Product Name

        Keyword Search

    • Featured Products
  • News
  • Library
  • Facilities
  • Regions
  • Contacts
Bimeda UK - Items filtered by date: July 2016

Bimeda UK is proud to communicate the launch of their guide to selective dry cow therapy. The 8 page, A5 guide is available to vets throughout the UK, who wish to consider a move to selective dry cow therapy (SDCT) for some of their clients. The guide will assist vets in explaining the criteria for SDCT to their clients, and is a key educational material which will assist the appropriate reduction in the use of dry cow antibiotics. Bimeda is committed to adding value to the UK veterinary and farming sectors, through the creation of educational training materials, among many other activities. Bimeda is known within the UK for providing consistently high quality products at a fair price and within its dairy production category, is known for products such as Boviseal non-antibiotic teat seal, Multishield Dry Cow and Coseicure nutritional boluses.

Published in News

Bimeda UK is pleased to announce the re-launch of Multishield Dry Cow (POM-V) to the UK market place.

The non-cephalosporin containing dry cow tube contains 100mg Neomycin Sulphate, 100mg Penethemate Hydriodide and 400mg Procaine Benzylpenicillin and is a welcome addition to Bimeda’s growing dairy production category, which includes such products as Boviseal non-antibiotic teat sealant, as well as a range of anti-inflammatories, anti-microbials and anti-parasitics, hormones and nutritional products licensed for use in dairy cattle.

Bimeda Professional Services Veterinarian, Rachel Mallet BVM&S MRCVS, commented; ‘Multishield DC treats a wide variety of mastitis-causing bacteria. With its fast and slow-release penicillin, Multishield DC offers fast-acting yet prolonged activity. The fact that it works synergistically with the other ingredients makes this a great option for UK farmers at dry-off. UK vets have been eagerly anticipating the re-introduction of Multishield, which is an excellent choice for use as part of a mastitis control programme, in conjunction with teat sealants such as Boviseal. While Boviseal acts as a physical barrier to prevent new infection, Multishield DC treats existing infections’.

Multishield DC has a meat withdrawal of 28 days and a milk withdrawal of 96 hours post-calving in cows with a dry period of more than 50 days. Each pack contains 120 syringes.

To coincide with the relaunch of Multishield DC, Bimeda is launching their guide to Selective Dry Cow Therapy. Rachel noted; ‘worldwide, the animal health industry is coming under increasing pressure to move away from a ‘blanket approach’ to antibiotic use, towards a more targeted approach. However, for some farmers this is a completely new concept and there is a significant knowledge gap in this area. We have produced the Bimeda Guide To Selective Dry Cow Therapy which is a tool for vets to use in conjunction with their clients, to help them understand when and how it is appropriate to introduce a selective dry cow therapy approach, which should only be introduced in consultation with a vet’.

Head of Sales for Bimeda UK, James Hutchings, commented, ‘the reintroduction of Multishield and the launch of our training materials and literature highlights our ongoing commitment to providing the UK veterinary sector with both high quality products at a competitive price point, as well as the support materials they need to help their farming clients introduce best-practice on-farm protocols’.

For more information on Multishield DC, or if you would like to order the free-of-charge Bimeda Guide To Selective Dry Cow Therapy, contact your Bimeda Sales Representative or call Bimeda on 01248 725 400

Multishield DC is registered POM-V medicine. Vm: 12597/4058. Full product information, including contra-indications, can be found on the SPC which is available on the VMD website. Alternatively, see Bimeda.co.uk.

Use Medicines Responsibly. www.noah.co.uk

Published in News

Bimeda is pleased to be attending the 2016 World Buiatrics Congress, which is taking place in Dublin this year and which is attended by over 3000 delegates.

Bimeda’s wide range of animal health and veterinary pharmaceutical products and their global footprint, means that the Bimeda trade stand is proving extremely popular with congress delegates. Bimeda representatives from Ireland, Brazil, the UK and China were on hand to talk to delegates about key health issues affecting cattle globally, and about Bimeda products and services.

Bimeda offer a wide range of products which are suitable for use in both dairy and beef cattle, ranging from parasite control products, to nutritional boluses and veterinary pharmaceuticals. Day one saw huge interest in Bimeda’s range of Cosecure nutritional boluses, as well as in Bimeda’s non-antibiotic teat sealant, Boviseal. Mary Murphy, Marketing Manager commented, ‘as veterinarians and their farming clients increasingly move to a preventative approach to herd health, ensuring the optimum trace element status of animals becomes increasingly important and we saw a huge interest in our Cosecure range of trace element boluses on day one. There was also a great deal of interest in Boviseal non-antibiotic teat sealant, which is currently used to prevent mastitis in over 70% of Ireland’s dairy herd’.

Bimeda are attending the Congress all week and invite all delegates to visit the stand and talk to Bimeda sales representatives and Bimeda veterinarians.

Published in News

Bimeda UK is pleased to announce the launch of Tetroxy Vet injection (200mg/ml oxytetracycline, POM-V). The range is the latest addition to the company’s broad and expanding dairy-production category.

Head of Sales for Bimeda UK, James Hutchings, commented; ‘the launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price.’

Tetroxy Vet is indicated in the treatment and control of diseases caused by, or associated with, organisms sensitive to Oxytetracycline in cattle, sheep
and pigs.

Benefits of Tetroxy Vet include:

High syringe-ability: the product injects well event at cold temperatures.

Flexibility: Tetroxy Vet is licensed for use in cattle, sheep and pigs and can be administered to lactating animals

Fast-acting: yet long-acting: Tetroxy Vet provides rapid initial blood levels of oxytetracycline, followed by a long-acting effect.

Tetroxy Vet is available in a 100ml pack size.

Bimeda manufactures a wide range of veterinary pharmaceuticals and animal health products. In the UK, the company focuses on four key categories: dairy production, parasite control, nutrition and equine.

For further information on any Bimeda product, contact your local Bimeda Territory manager or call Bimeda on 01248 725 400.

Use Medicines Responsibly. Noah.co.uk/responsible
Date press release prepared: July 2016. For full product information, including contra-indications, see the SPC which can be found on the VMD website. Bimeda can be contacted at Unit 2, Bryn Cefni Industrial park, Llangefni, LL777XA, or call 01248 725 400.

Published in News